Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chromosomal abnormalities in leiomyosarcomas

C Sreekantaiah1, J R Davis, A A Sandberg

  • 1Memorial Sloan-Kettering Institute, Laboratory of Genetics and Cancer Genetics, New York.

The American Journal of Pathology
|January 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cytogenetic and pathologic aspects of Ewing's sarcoma and neuroectodermal tumors.

Human pathology·1992
Same author

Translocation (X;1)(p11.2;q21). A subtype of renal adenocarcinomas.

Cancer genetics and cytogenetics·1992
Same author

Cytogenetic and molecular studies of a familial renal cell carcinoma.

Cancer genetics and cytogenetics·1992
Same author

Cytogenetic and fluorescence in situ hybridization analysis of breast fibroadenomas.

Cancer genetics and cytogenetics·1992
Same author

Application of fluorescence in situ hybridization in hematological disorders.

Cancer genetics and cytogenetics·1992
Same author

Cytogenetic and FISH studies of abnormal X chromosomes in a patient with ANLL.

Cancer genetics and cytogenetics·1992
Same journal

Lxrα Deficiency Primes Retinal Degeneration, but Aging Drives Disease Severity.

The American journal of pathology·2026
Same journal

MYC is functionally required in both normal and neoplastic Meibomian glands.

The American journal of pathology·2026
Same journal

Fumaric Acid Esters as Modulators of Ocular Inflammation and Angiogenesis.

The American journal of pathology·2026
Same journal

Krüppel-like factor 5 inhibition rescues cavernous nerve-injured erectile dysfunction by preventing phenotypic switch and mitochondrial dysfunction-dependent apoptosis in corpus cavernosum smooth muscle cells.

The American journal of pathology·2026
Same journal

APOE4 as a Modifier of Chemotherapy Response.

The American journal of pathology·2026
Same journal

Spatial Pathobiology in the Omics Era: Transforming Modern Pathology.

The American journal of pathology·2026
See all related articles

Cytogenetic analysis of leiomyosarcoma revealed chromosomal abnormalities in over half of the tumors studied. Specific recurrent rearrangements and numerical losses were identified, offering insights into leiomyosarcoma pathogenesis.

Area of Science:

  • Cytogenetics
  • Oncology
  • Molecular Biology

Background:

  • Leiomyosarcoma is a malignant mesenchymal tumor arising from smooth muscle tissue.
  • Understanding the genetic basis of leiomyosarcoma is crucial for diagnosis and treatment.
  • Previous cytogenetic studies have identified various chromosomal alterations in leiomyosarcomas.

Purpose of the Study:

  • To perform cytogenetic assessment of leiomyosarcoma specimens.
  • To identify recurrent chromosomal abnormalities in leiomyosarcoma.
  • To correlate chromosomal changes with potential oncogenes and tumor suppressor genes.

Main Methods:

  • Short-term culture and cytogenetic analysis of 38 leiomyosarcoma tumors from 30 patients.
  • Specimens were obtained from retroperitoneum, gastrointestinal tract, and extremities.

Related Experiment Videos

  • Karyotyping was performed to detect numerical and structural chromosomal aberrations.

    • Main Results:

    • Chromosomal abnormalities were detected in 18 of 38 tumors (13 patients).
    • Fifteen tumors exhibited clonal chromosomal changes, with varying ploidy (near-diploid, polyploid, bimodal).
    • Consistent structural rearrangements involved chromosomes 1, 7, 10, 13, and 14; recurrent numerical losses included chromosomes 4, 9, 14-16, 18, 21, and 22.

    Conclusions:

    • No single karyotypic change definitively characterizes leiomyosarcoma, but specific chromosomal regions are frequently altered.
    • Identified chromosomal abnormalities may harbor oncogenes, tumor suppressor genes, or growth factor genes.
    • Further molecular analysis of these sites could elucidate leiomyosarcoma pathogenesis and identify therapeutic targets.